BLT - Blis Technologies

[Left Field]

Life in the old dog yet?

Rare revenue upgrade!

https://www.nzx.com/announcements/429533

Blis Technologies Limited (NZX:BLT) advises that the draft full year financial results for the 12 months to 31 March 2024 have exceeded previous guidance due to favourable timing of several major customer orders, increased sales across our B2B channels and an underspend in some planned R&D expenditure for this year.

Our latest guidance for the year ended 31 March 2024 is for revenue of $11.5m and EBITDA of $0.8m subject to completion of the annual financial audit.

This is an increase on the previous guidance provided on 23rd February 2024 of revenue of around $11.0m and EBITDA of breakeven to $0.3m.

Blis Technologies' annual report and financial statements are expected to be released in late May.

[Left Field]

A long time ago I doubled my money in BLT and then moved on..... so for sentimental reasons it's nice to see BLT is now doing OK (however I wonder if its worth it being on the NZX?)

https://www.nzx.com/announcements/431666

In the year to 31 March 2024, Blis Technologies Ltd (Blis) achieved a return to profitability after two years of operating losses. The profit for the year was $0.6m, which was in line with guidance. This result was achieved on revenue of $11.5m, which was 12.6% higher than the previous year.

Revenue growth was achieved in our Business to Business (B2B) segment, with an 18.2% increase in ingredient sales and royalty income. Revenue in the Business to Consumer (B2C) area was affected by cost of living pressures on our customers and as a result revenue was consistent with the previous year. The revenue growth combined with a tight control over costs resulted in an improved trading performance. Net profit after tax for the year of $0.6m compares with a loss of $1.4m in the previous financial year.

[Left Field]

Trading halt called..... not looking good... just as BLT were making progress...

Reasons for trading halt, including impact of event on fair orderly or transparent
markets: The company has become aware of a patent filing that potentially has a significant
impact on the company. The company needs time to assess those impacts including obtaining
legal advice.

https://api.nzx.com/public/announcement/438468/attachment/427641/438468-427641.pdf

[winner (n)]

existential crisis Looming

[Pierre]

Trading halt called..... not looking good... just as BLT were making progress...

Reasons for trading halt, including impact of event on fair orderly or transparent
markets: The company has become aware of a patent filing that potentially has a significant
impact on the company. The company needs time to assess those impacts including obtaining
legal advice.

https://api.nzx.com/public/announcement/438468/attachment/427641/438468-427641.pdf

It wouldn't be Blis if there wasn't a crisis looming just as the wheels look they're about to turn - again. Sigh!

[Left Field]

Market update on the competitive patent application.

BLT case looks strong......but progress will come at a cost.

https://www.nzx.com/announcements/438596

Blis Technologies Limited (BLIS) wishes to advise the market that it has become aware that a key customer has filed a patent for the BLIS K12™ and BLIS M18™ fermentation process in 3 key jurisdictions, being the USA, Europe and China.
 
 Also named on the patent registration as inventors are two employees of a European manufacturer which ferments probiotics. BLIS previously worked with this manufacturer to ferment the BLIS strains and disclosed its trade secrets to them as part of this process under a Non-Disclosure Agreement (NDA).
 
 The wording on the patent application contains wording and provisions which, in some instances, are identical or almost identical to information BLIS provided to the European manufacturer. BLIS is concerned by the release of its confidential information in the patent application and the potential impact that this may have on BLIS' ongoing operations.
 
 The release of BLIS' trade secrets and confidential information, as part of the patent application, has considerable financial implications for the company. A reduction in revenue is expected in the short term due to less sales of BLIS' probiotic ingredients. It is expected that this key customer will terminate its arrangement with BLIS as a result of its patent application.
 
 BLIS has sought legal advice in relation to this matter. BLIS will challenge the patent application and take action against the European manufacturer and the key customer for their alleged breaches. Additional costs will be incurred by BLIS as a result.
 On this basis the guidance provided by BLIS on 22 August 2024 is withdrawn.
 
 BLIS has cash reserves it can rely on whilst it works on alternative strategies to address these challenges.
 

[Toddy]

It's sad when these situations happen. What a major distraction to the business and more than likely financially material.

I wish them luck.

[Untamed]

Boy, has this company has turned out to be a disaster. Just saw a post elsewhere that reminded me I used to hold a few.

I bought in, in Jan 2020 at $0.07
Sold Feb 2021 at $0.066

And today they are sitting at $0.014

Anyone still hold? Has there been any outcome on the patent situaton?

[lorraina]

Strong YTD performance
19/02/2026, 08:30 NZDT, MKTUPDTE
19 February 2026

Strong YTD performance

For the third quarter (3Q26) ending 31 December 2025, BLIS Technologies Limited (BLIS) achieved revenue of $3.1m, although being 3% behind the same period last year, the nine months revenue to 31 December 2025 was $10.8m, an increase of $1.5m (17%) on the same period last year.

The EBITDA result for 3Q26 is $0.3m, the same as for the same period last year. For the nine months to 31 December 2025 (YTD), underlying EBITDA is $1.7m after adjusting for the one off supply chain costs noted in previous market updates. Reported EBITDA is $0.8m being an increase of 44% on the same period last year.

"Year to date revenue growth has predominantly come from a $1.4m (21%) increase in B2B revenues, a combination of strong orders from existing ingredient customers, new ingredient customer activity in APAC and growth of private label revenue. Total B2C revenue has grown by $0.3m (9%), with strong performance in the NZ Wholesale channel." said Scott Johnson, CEO.

"Over the past months, BLIS collaborated closely with Probi AB to revise their joint business plans, aiming to advance the oral probiotics program for both humans and pets. This was a result of the extension of the existing Technology License & Distribution Agreement. This relationship is key to delivering future growth in our B2B business." said Scott Johnson, CEO.

BLIS' full year revenue is forecast to be in excess of $14m, with reported EBITDA in the range of $0.8m to $1.1m, subject to completion of the annual financial audit.

Ends

[lorraina]

BLT Bliss enjoying a "break out" currently.Trading at over .02 at .021 .
RSI High at 76.96;
Lowest seller only has for sale 9,046 shares at .022.

For anyone who does not know what RSI stands for.;
 (RSI), a momentum oscillator, to analyze price trends and identify overbought or oversold conditions in financial markets.

[Otago K]

BLT Bliss enjoying a "break out" currently.Trading at over .02 at .021 .
RSI High at 76.96;
Lowest seller only has for sale 9,046 shares at .022.

For anyone who does not know what RSI stands for.;
 (RSI), a momentum oscillator, to analyze price trends and identify overbought or oversold conditions in financial markets.

mmm, so I assume that I might need to up my BUY above 1.9c then.

[winner (n)]

BLT Bliss enjoying a "break out" currently.Trading at over .02 at .021 .
RSI High at 76.96;
Lowest seller only has for sale 9,046 shares at .022.

For anyone who does not know what RSI stands for.;
 (RSI), a momentum oscillator, to analyze price trends and identify overbought or oversold conditions in financial markets.

RSI that high says 'overbought' doesn't it percy ...with trend reversal a possibility

[lorraina]

Yes often the case,but also often goes higher.
However..?.Just after I posted only 9,046 for sale at.022, sellers appeared with over 1mil shares for sale at .021.....
Just love the market....lol

[HAWKDOG]

chart shows a break out from a long base.  will be interesting to see if it continues.

[HAWKDOG]

BLT - Strong 1Q27 supports growth outlook

BLIS Technologies Limited (BLIS) delivered revenue of $5.1m, for the first quarter ended 30 June 2026 (1Q27), an increase of $1.5m, or up 42%, on the same period last year. 1Q27 EBITDA was a $1.1m profit compared to a $0.2m loss for 1Q26

http://www.sharechat.co.nz/article/92c1986f/blt-strong-1q27-supports-growth-outlook.html